Penumbra Inc (PEN) stock news · P/E 80, rev $1.40B
Penumbra Inc (PEN) is a medical devices company listed on US.
This PEN news page leads with what Penumbra Inc filed — not a scraped headline mill.
No cached 8-K sentence for PEN yet. We will not pad this page with generic market recap.
Latest reported PEN revenue for 2025-12-31 was $1.40B. Net income was $177.7M. Revenue was up 17.5% from 2024-12-31 to 2025-12-31. PEN currently screens at market cap $9.93B and trailing P/E 79.7.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the PEN stock page; for the tape open the quote page.
PEN stock news FAQ
What are PEN's latest revenue and net income?
Latest cached Penumbra Inc (PEN) revenue for Dec 31, 2025 was $1.40B. Net income was $177.7M. Statements: https://lician.com/financials/pen
How did PEN revenue change from the prior cached period?
Cached Penumbra Inc (PEN) revenue was up 17.5% from $1.19B (Dec 31, 2024) to $1.40B (Dec 31, 2025). Statements: https://lician.com/financials/pen
What is PEN's P/E ratio?
Penumbra Inc (PEN) trailing P/E is 79.7 on the latest cached fundamentals snapshot.
What is PEN's market cap?
Penumbra Inc (PEN) market cap is $9.93B on the latest cached fundamentals snapshot.
What kind of company is PEN?
Penumbra Inc (PEN) is a medical devices company listed on US.
Where is PEN stock news listed?
Cached stock news for Penumbra Inc (PEN) is listed at https://lician.com/news/pen. Filings: https://lician.com/sec/pen
Not investment advice.